Olon S.p.A. is an Italian Company, a world leading Active Pharmaceutical Ingredients Manufacturer, with Headquarters and 5 manufacturing facilities located in Italy, and originates from the merger of the previous Solmag and Antibioticos S.p.A.
Olon S.p.A. also acquired INFA Group, an Italian APIs developer and manufacturer operating worldwide with 3 manufacturing facilities (2 located in Italy and 1 in Spain).
The different know how combined with internationally oriented culture lead the Company to improve its products portfolio and strengthen its presence in the global generics market.
Focus was directed to regulated and partially regulated markets worldwide, and the continuous growth is supported also through the 2 subsidiaries Olon USA Inc. and P&R Shanghai – International Trading Co.
Olon USA Inc.
The wholly owned subsidiary meant to strengthen Olon’s position in the U.S. market.
P&R Shanghai – International Trading Co.
International trading company focused on providing qualified sources and services in the Far East for the Group, as well as developing commercial partnerships for local distribution.
Olon S.p.A.’s Mission is to be a world leader in the manufacturing and sales of advanced intermediates and active pharmaceutical ingredients (APIs) for human's and animal's health.
We have more than a century experience in fermentation and are one of the most important players in the production of High Potency Drugs, as well as cytotoxic substances, with dedicated high containment facilities.
Antineoplastic compounds, immunosuppressive agents, hormones and antibiotics, retinoids, antivirals, psychotropic and controlled substances as well as compounds for CNS, cardiovascular and metabolic diseases complete our wide product portfolio.
Our expertise can be summarized as follows: